4.3 Article

A Once-Daily High Dose of Intraperitoneal Ascorbate Improves Vestibulo-ocular Reflex Compensation After Unilateral Labyrinthectomy in the Mouse

Publisher

SPRINGER
DOI: 10.1007/s10162-021-00831-1

Keywords

ascorbate; efferent vestibular system; vestibular compensation; vestibulo-ocular reflex; vestibular plasticity

Funding

  1. National Health and Medical Research Council of Australia (NHMRC) Biomedical Career Development Award [CDA568736]
  2. NHMRC [APP1010896]

Ask authors/readers for more resources

This study investigated the effect of ascorbate on the recovery of vestibulo-ocular reflex (VOR) after labyrinthectomy. The results showed that treatment with ascorbate reduced acute loss and aided in the recovery during the acute to chronic compensation stages. One possible mechanism is that ascorbate enhances the vestibulo-ocular reflex pathway, increasing the number and sensitivity of vestibular afferents.
Ascorbate potentiates the response of nicotinic-acetylcholine-receptors containing alpha 9 and alpha 10 subunits found predominantly in the efferent systems of the inner ear, such as the efferent vestibular system (EVS). Prior mouse studies have shown that an attenuated EVS results in reduced vestibulo-ocular reflex (VOR) gain (=eye_velocity/head_velocity) plasticity in intact (VOR adaptation) and surgically-lesioned (VOR compensation) mice. We sought to determine whether ascorbate-treatment could improve VOR recovery after vestibular organ injury, possibly through potentiation of the EVS pathway. We tested 10 cba129 mice, 5 received ascorbate-treatment and 5 did not, but otherwise experienced the same conditions. Ascorbate-treatment comprised a once-daily intraperitoneal injection of L-form reduced ascorbate (4 g/kg) in 0.2 ml saline starting 1 week before, and ending 4 weeks after, unilateral labyrinthectomy surgery. These were deliberately high doses to determine the ascorbate effects on recovery. Baseline, acute, and chronic sinusoidal VOR gains (frequency and velocity ranges: 0.2-10 Hz, 20-100 deg/s) were measured 3-5 days before, 3-5 days after, and 28-31 days after labyrinthectomy. Mice treated with ascorbate had acute ipsilesional VOR gains 12 % higher compared to control mice (+45.2 +/- 14.9 % from baseline versus +33.7 +/- 15.4 %, P < 0.001). Similarly, chronic ipsilesional and contralesional VOR gains were respectively 16 % (+74.3 +/- 16.3 % from baseline versus +58.1 +/- 15.8 %, P < 0.001) and 13 % (+78.6 +/- 16.0 % versus +65.6 +/- 10.9 %, P < 0.001) higher compared to control mice. These data suggest ascorbate-treatment had a prophylactic effect reducing acute loss, and helped recovery during acute to chronic stages of compensation. One possible mechanism is that an ascorbate-enhanced EVS drives an increase in the number and sensitivity of irregular-discharging primary vestibular afferents, important for VOR plasticity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available